BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 72 filers reported holding BEAM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,734,576 | -24.7% | 321,604 | 0.0% | 0.50% | -10.0% |
| Q2 2023 | $10,268,815 | +4.3% | 321,604 | 0.0% | 0.55% | +1.1% |
| Q1 2023 | $9,847,514 | -21.7% | 321,604 | 0.0% | 0.55% | -25.3% |
| Q4 2022 | $12,577,932 | -17.9% | 321,604 | 0.0% | 0.73% | -6.5% |
| Q3 2022 | $15,321,000 | +23.1% | 321,604 | 0.0% | 0.78% | +15.7% |
| Q2 2022 | $12,449,000 | -32.4% | 321,604 | 0.0% | 0.68% | +13.0% |
| Q1 2022 | $18,428,000 | -28.1% | 321,604 | 0.0% | 0.60% | -3.4% |
| Q4 2021 | $25,629,000 | -8.4% | 321,604 | 0.0% | 0.62% | -6.8% |
| Q3 2021 | $27,983,000 | -65.8% | 321,604 | -49.4% | 0.66% | -60.2% |
| Q2 2021 | $81,806,000 | +59.5% | 635,586 | -0.8% | 1.67% | -19.4% |
| Q1 2021 | $51,289,000 | -5.3% | 640,792 | -3.5% | 2.07% | -20.5% |
| Q4 2020 | $54,184,000 | +231.6% | 663,691 | 0.0% | 2.60% | +238.5% |
| Q3 2020 | $16,340,000 | -12.1% | 663,691 | 0.0% | 0.77% | -10.5% |
| Q2 2020 | $18,583,000 | +55.6% | 663,691 | 0.0% | 0.86% | +9.4% |
| Q1 2020 | $11,946,000 | – | 663,691 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |